CXCL1 and melanoma: Enrichment of Hsp90/p‐IKKα/β complex in hypoxic melanoma-derived EVs can activate the IKK/IκB/NF‐κB signaling pathway, leading to increased expression of CXCL1 and promoting melanoma angiogenesis and progression [126].